Stephanie Schafer
Family · Cave Creek, AZNPI 1093202731
Payments from drug & device makers
Across 241 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$928
- UCB, Inc.$559
- Regeneron Healthcare Solutions, Inc.$379
- Dermavant Sciences, Inc.$315
- Galderma Laboratories, L.p.$288
- Sanofi$273
- plus $2K from 15 others
What the payments were for
- Food & beverage$4,43098%
- Education$1092%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $928 |
| UCB, Inc. | 23 | $559 |
| Regeneron Healthcare Solutions, Inc. | 13 | $379 |
| Dermavant Sciences, Inc. | 21 | $315 |
| Galderma Laboratories, L.p. | 26 | $288 |
| Sanofi | 9 | $273 |
| Johnson & Johnson | 13 | $267 |
| E.r. Squibb & Sons, L.L.C. | 17 | $238 |
| Lilly USA, LLC | 10 | $215 |
| Novartis | 7 | $184 |
| Incyte Corporation | 10 | $183 |
| Sun Pharmaceutical Industries Inc. | 6 | $129 |
| Genentech USA, Inc. | 4 | $121 |
| Organon | 11 | $114 |
| Kyowa Kirin, Inc. | 4 | $112 |
| Pfizer | 5 | $81 |
| Amgen | 4 | $71 |
| Botanix SB Inc | 2 | $41 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Almirall LLC | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $8 |
How this compares
$4,539 in reported general payments places this provider in the 90th percentile of 4,119 family providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 13 | $287,787 |
| Dupixent PenDupilumab | 45 | $209,822 |
| Clobetasol Propionate | 200 | $9,660 |
| Tacrolimus | 43 | $7,676 |
| Fluorouracil | 88 | $6,864 |
| Ketoconazole | 174 | $2,653 |
| Clindamycin Phosphate | 56 | $2,327 |
| Triamcinolone Acetonide | 115 | $1,272 |
| Betamethasone Dipropionate | 11 | $1,038 |
| Doxycycline Monohydrate | 63 | $799 |
| Metronidazole | 13 | $739 |
| Hydrocortisone | 85 | $582 |
| Cephalexin | 58 | $455 |
| Mupirocin | 39 | $316 |
| Ciclopirox | 14 | $290 |
Paid to pharmacies, not to this prescriber.
Other family in Cave Creek
- Sharon MagalonaMesa$449K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Rebecca McCollaumMesa$149K
- Susan SarabiaSun City West$114K
- Lindsay CarterTucson$108K
- Audrey StevensonPhoenix$83K
- Keith MorsePrescott$83K
- Celeste FineGilbert$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.